Related Experiment Video
Updated: Jul 27, 2025

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF
Sevilay Vural1,2, Mikail Kuşdoğan2, Hasan Burak Kaya2
1Department of Emergency Medicine, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Abstract:
Anti-tumor necrosis factor agents are widely used in treating ankylosing spondylitis, but they increase the risk of infection by suppressing the immune response. Therefore, physicians should be careful about recurrent infections in patients under anti-tumor necrosis factor agents.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tonsillitis II: Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Pyelonephritis II: Diagnostic Studies and Management
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

